Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0371420200990020097
Annals of Surgical Treatment and Research
2020 Volume.99 No. 2 p.97 ~ p.109
Oncologic effects of adjuvant chemotherapy in patients with ypT0?2N0 rectal cancer after neoadjuvant chemoradiotherapy and curative surgery: a meta-analysis
Ha Gi-Won

Lee Min-Ro
Abstract
Purpose: The role of adjuvant chemotherapy for patients with ypT0?2N0 rectal cancer following neoadjuvant chemoradiotherapy (nCRT) and curative surgery is uncertain. We performed a meta-analysis using selected studies to compare adjuvant chemotherapy with observation for this cohort of patients.

Methods: PubMed, Embase, and the Cochrane Library were searched. Data were pooled, and overall effect size was calculated using random effect models. Outcome measures were 5-year overall survival (OS), disease-free survival (DFS), local, and distant recurrence.

Results: We included 17 nonrandomized studies for qualitative analysis and 16 nonrandomized studies that examined 4,747 patients for the meta-analysis. In analysis of patients with ypT0N0 rectal cancer, adjuvant chemotherapy had no significant effect on OS (odds ratio [OR], 1.53; 95% confidence interval [CI], 0.86?2.72; I2 = 27%), DFS (OR, 1.22; 95% CI, 0.61?2.42; I2 = 5%), local recurrence (OR, 0.78; 95% CI, 0.08?7.37; I2 = 0%), and distant recurrence (OR, 1.04; 95% CI, 0.41?2.62; I2 = 0%). In analysis of patients with ypT1?2N0 rectal cancer, adjuvant chemotherapy also had no significant effect on OS (OR, 2.15; 95% CI, 0.59?7.80; I2 = 26%), DFS (OR, 1.66; 95% CI, 0.35?7.85; I2 = 44%), local recurrence (OR, 2.56; 95% CI, 0.72?9.13; I2 = 0%), and distant recurrence (OR, 1.15; 95% CI, 0.23?5.87; I2 = 0%).

Conclusion: Adjuvant chemotherapy may have no oncologic benefits in patients with ypT0?2N0 rectal cancer after nCRT and radical surgery. Routine use of adjuvant chemotherapy for those patients may be avoided.
KEYWORD
Adjuvant chemotherapy, Chemoradiotherapy, Prognosis, Rectal neoplasms
FullTexts / Linksout information
  
Listed journal information
SCI(E) ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø